di-tert-butyl (2-bromo-4-methylphenyl)imidodicarbonate | 880384-50-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: di-tert-butyl (2-bromo-4-methylphenyl)imidodicarbonate
• 英文别名: tert-butyl N-(2-bromo-4-methylphenyl)-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate
• CAS: 880384-50-9
• 化学式: C₁₇H₂₄BrNO₄
• 分子量: 386.286
• InChiKey: NXHYNHSNGGEUJP-UHFFFAOYSA-N

物化性质

• 沸点：
  416.1±55.0 °C(Predicted)
• 密度：
  1.291±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.9
• 重原子数：
  23
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.53
• 拓扑面积：
  55.8
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  di-tert-butyl (2-bromo-4-methylphenyl)imidodicarbonate 在 N-溴代丁二酰亚胺(NBS) 、 偶氮二异丁腈 作用下， 以 三氟甲苯 为溶剂， 反应 3.0h， 生成 di-tert-butyl [2-bromo-4-(bromomethyl)phenyl]imidodicarbonate
  参考文献：
  名称：

  [EN] MACROCYCLIC KINASE INHIBITORS
  [FR] INHIBITEURS DE KINASE MACROCYCLIQUES

  摘要：

  式(I)的化合物：其中变量在此处定义，并且其药用盐、合成、中间体、配方和治疗疾病的方法，包括对FAK抑制有益的癌症。

  公开号：

  WO2012074951A1
• 作为产物：
  描述：

  二碳酸二叔丁酯 、 2-溴-4-甲基苯胺 以 四氢呋喃 为溶剂， 以80%的产率得到di-tert-butyl (2-bromo-4-methylphenyl)imidodicarbonate
  参考文献：
  名称：

  Short and Simple Preparation ofN-Boc-Protected Anthranilic Acidtert-Butyl Esters from 2-Bromo-Anilines

  摘要：

  本文描述了一种从邻溴苯胺制备二保护氨基苯甲酸衍生物的新型两步程序。

  DOI：

  10.1055/s-2005-921910

文献信息

• AMINO PYRIMIDINE ANTICANCER COMPOUNDS
  申请人：APPARI Rama Devi

  公开号：US20110136764A1

  公开（公告）日：2011-06-09

  Compounds of Formula 1, as shown below and defined herein: and pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancers mediated at least in part by FAK.

  以下为化学式1的化合物，本文中定义：以及其药学上可接受的盐、合成、中间体、制剂和治疗该疾病的方法，包括至少部分由FAK介导的癌症。
• MACROCYCLIC KINASE INHIBITORS
  申请人：Crew Andrew P.

  公开号：US20130261086A1

  公开（公告）日：2013-10-03

  Compounds of Formula (I): wherein variables are defined herein, and pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancers for which FAK inhibition is beneficial.

  公式（I）的化合物：其中变量在此定义，并且是药学上可接受的盐，合成，中间体，制剂以及使用其进行疾病治疗的方法，包括FAK抑制对其有益的癌症。
• Amino pyrimidine anticancer compounds
  申请人：Appari Rama Devi

  公开号：US08399433B2

  公开（公告）日：2013-03-19

  Compounds of Formula 1, as shown below and defined herein: and pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancers mediated at least in part by FAK.

  以下式子所示的化合物1及其药学上可接受的盐，合成、中间体、制剂和使用它们治疗疾病的方法，包括至少部分由FAK介导的癌症的治疗方法。
• Macrocyclic kinase inhibitors
  申请人：Crew Andrew P.

  公开号：US09133224B2

  公开（公告）日：2015-09-15

  Compounds of Formula (I): wherein variables are defined herein, and pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancers for which FAK inhibition is beneficial.

  公式（I）的化合物：其中变量在此处定义，以及与之相关的药物可接受的盐，合成，中间体，配方和治疗该疾病的方法，包括FAK抑制对其有益的癌症。
• Indole Synthesis by Controlled Carbolithiation of <i>o</i>-Aminostyrenes
  作者：Albane Kessler、Claire M. Coleman、Patchanee Charoenying、Donal F. O'Shea

  DOI：10.1021/jo048723e

  日期：2004.11.1

  An effective synthesis of the functionalized indole ring system has been developed from substituted o-aminostyrene starting material. Our methodology involves a novel cascade reaction sequence of alkyllithium addition to the styrene double bond and subsequent trapping of the intermediate organolithium with a suitable electrophile, followed by an in situ ring closure and dehydration to generate the indole ring. This new reaction sequence allows for the introduction of molecular diversity at all positions on the indole scaffold. The procedure was shown to be successful with a range of both C and N substituents on the o-aminostyrenes. The reaction sequence was tolerant to the reactivity range of alkyllithiums such as tert-, sec-, and n-butyllithium. The electrophiles used were DMF, which generated indole products with C-2 unsubstituted, and nitriles, which incorporated the nitrile substituent at C-2. The o-aminostyrene starting materials were generated by a Pd-catalyzed cross-coupling reaction of a vinyl boronic acid equivalent with the readily available substituted o-bromoanilines.